Ben J. Lawrence

2.6k citations

58 papers · 2.0k · 1 hit paper · h-index 19

Impact in

Epidemiology top 1%
- Neuroendocrine Tumor Research Advances
Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes

Papers in

Epidemiology 35
- Neuroendocrine Tumor Research Advances 35
Oncology 8
- Pancreatic and Hepatic Oncology Research 4
- Polyomavirus and related diseases 3

Co-authors: Irvin Mark Modlin (16 shared papers)Mark S. Kidd (18 shared papers)Bernhard Svejda (10 shared papers)Björn Inge Gustafsson (4 shared papers)Anthony K. C. Chan (1 shared paper)Simon J. Schimmack (11 shared papers)Roswitha Pfragner (4 shared papers)Daniele Alaimo (6 shared papers)
Journals: Langenbeck s Archives of Surgery (3 papers)Neuroendocrinology (3 papers)Endocrinology and Metabolism Clinics of North America (2 papers)Annals of Oncology (2 papers)Cancer (2 papers)
Partner nations: New Zealand United States Australia

In The Last Decade

Ben J. Lawrence

55 papers receiving 1.9k citations

Ben J. Lawrence's Hit Papers

align trajectories log scale

The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors 2011 · 681 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2011 Endocrinology and Metabolism Clinics of North America

Peers

Countries citing papers authored by Ben J. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Ben J. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben J. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben J. Lawrence more than expected).

Fields of papers citing papers by Ben J. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben J. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben J. Lawrence. The network helps show where Ben J. Lawrence may publish in the future.

Co-authors

The 25 scholars most cited alongside Ben J. Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben J. Lawrence Line = papers co-authored together Ben J. Lawrence links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben J. Lawrence, Björn Inge Gustafsson, Anthony K. C. Chan, Bernhard Svejda, Mark S. Kidd, Irvin Mark Modlin Hit paper breakdown →	2011	681
2	Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer Annals of Oncology ·Belinda Lee, Lara Rachel Lipton, Joshua David Cohen, Jeanne Tie, Ammar A. Javed, Lan A. Li, David Goldstein, Matthew Burge	2019	182
3	The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben J. Lawrence, Björn Inge Gustafsson, Mark S. Kidd, Bernhard Svejda, Irvin Mark Modlin +1 other	2011	131
4	The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors Langenbeck s Archives of Surgery ·Simon J. Schimmack, Bernhard Svejda, Ben J. Lawrence, Mark S. Kidd, Irvin Mark Modlin	2011	127
5	Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines Journal of Thoracic Oncology ·Simron Singh, Emily K. Bergsland, Cynthia M. Card, Thomas A. Hope, Pamela L. Kunz, David T. Laidley, Ben J. Lawrence, Simone Leyden	2020	89
6	A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival Neuroendocrinology ·Irvin Mark Modlin, Björn Inge Gustafsson, Marianne Pavel, Bernhard Svejda, Ben J. Lawrence, Mark S. Kidd	2010	75
7	Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT Cancer ·Bernhard Svejda, Mark S. Kidd, Alexander D. Kazberouk, Ben J. Lawrence, Roswitha Pfragner, Irvin Mark Modlin	2011	74
8	Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors JAMA Oncology ·Simron Singh, Lesley Moody, David Lok Hang Chan, David C. Metz, Jonathan Strosberg, Timothy R. Asmis, Dale L. Bailey, Emily K. Bergsland	2018	73
9	Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer npj Genomic Medicine ·Ben J. Lawrence, Cherie Blenkiron, Kate Parker, Peter Tsai, Sandra J. Fitzgerald, Paula Shields, Tamsin J. Robb, Mee Ling Yeong	2018	49
10	A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases Epigenetics & Chromatin ·Simon J. Schimmack, Andrew Taylor, Ben J. Lawrence, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Markus Wolfgang Büchler, Irvin Mark Modlin, Mark S. Kidd	2014	45
11	Serotonin and the 5‐ HT 7 receptor: The link between hepatocytes, IGF ‐1 and small intestinal neuroendocrine tumors Cancer Science ·Bernhard Svejda, Mark S. Kidd, Andrew T. Timberlake, Kathy Harry, Alexander D. Kazberouk, Simon J. Schimmack, Ben J. Lawrence, Roswitha Pfragner	2013	40
12	Effect of Education on the Recording of Medicines on Admission to Hospital Journal of General Internal Medicine ·Amy Hai Yan Chan, Elizabeth Garratt, Ben J. Lawrence, Nicholas Turnbull, Priya Pratapsingh, Peter Black	2010	34
13	The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant Langenbeck s Archives of Surgery ·Irvin Mark Modlin, Steven F. Moss, Björn Inge Gustafsson, Ben J. Lawrence, Simon J. Schimmack, Mark S. Kidd	2011	31
14	Quality of life is not influenced by the extent of surgery in patients with benign goiter Langenbeck s Archives of Surgery ·Friedrich Hubertus Schmitz-Winnenthal, Simon J. Schimmack, Ben J. Lawrence, Uwe Maier, Miriam Heidmann, Markus Wolfgang Büchler, Moritz von Frankenberg	2011	29
15	EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets Neuroendocrinology ·Mark S. Kidd, Simon J. Schimmack, Ben J. Lawrence, Daniele Alaimo, Irvin Mark Modlin	2012	29
16	A Clinical Perspective on Gastric Neuroendocrine Neoplasia Current Gastroenterology Reports ·Ben J. Lawrence, Mark S. Kidd, Bernhard Svejda, Irvin Mark Modlin	2010	27
17	PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis Cancers ·Gitta Boons, Timon Vandamme, Joe Ibrahim, Geert Roeyen, Ann L. C. Driessen, Dieter J. E. Peeters, Ben J. Lawrence, Cristin Gregor Print	2020	22
18	Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling Tumor Biology ·Simon J. Schimmack, Andrew Taylor, Ben J. Lawrence, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus Wolfgang Büchler, Irvin Mark Modlin, Mark S. Kidd	2014	21
19	Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals International Journal of Cancer ·Simone Leyden, Teodora R. Kolarova, Catherine Bouvier, Martyn Evan Caplin, Siobhan Conroy, Phillipa Davies, Sugandha Dureja, Falconi Massimo	2019	21
20	The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms Cancer ·Simon J. Schimmack, Ben J. Lawrence, Bernhard Svejda, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus Wolfgang Büchler, Mark S. Kidd	2011	17

About Ben J. Lawrence

Ben J. Lawrence is a scholar working on Epidemiology, Oncology, Cancer Research, Health and Geriatrics and Gerontology, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (35 papers), Pancreatic and Hepatic Oncology Research (4 papers), Polyomavirus and related diseases (3 papers), Cancer Genomics and Diagnostics (3 papers), Indigenous Health, Education, and Rights (2 papers), MicroRNA in disease regulation (1 paper), Extracellular vesicles in disease (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Epidemiology (1.3k citations), Geriatrics and Gerontology (26 citations), Cancer Research (89 citations), Oncology (139 citations) and Hepatology (17 citations). Ben J. Lawrence has collaborated with scholars based in New Zealand, United States and Australia. Frequent co-authors include Irvin Mark Modlin, Mark S. Kidd, Bernhard Svejda, Björn Inge Gustafsson, Anthony K. C. Chan, Simon J. Schimmack, Roswitha Pfragner, Daniele Alaimo, Markus Wolfgang Büchler and Marianne Pavel. Their work appears in journals such as Langenbeck s Archives of Surgery, Neuroendocrinology, Endocrinology and Metabolism Clinics of North America, Annals of Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ben J. Lawrence

Impact in

Papers in i

In The Last Decade

Ben J. Lawrence

Ben J. Lawrence's Hit Papers

Peers

Countries citing papers authored by Ben J. Lawrence

Fields of papers citing papers by Ben J. Lawrence

All Works

About Ben J. Lawrence

Explore authors with similar magnitude of impact

Papers in